CD8A and neoplasm: Constructed pH-responsive NPs for delivering Cas9 mRNA and guide RNAs targeting HPV E6/E7 oncogenes. Demonstrated effective gene editing, tumor suppression, and improved CD8 + T cell survival with adoptive T-cell transfer.